In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes

International Journal of Pharmaceutics

Volumn 313, Issue 1-2, 2006, Pages 181-188

  Han, Hee Dong ^a   Lee, Aeri ^a   Song, Chung Kil ^a   Hwang, Taewon ^a   Seong, Hasoo ^a   Lee, Chong Ock ^a   Shin, Byung Cheol ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

Biodistribution; Circulation time; Heparin conjugation; Liposome

Indexed keywords

DOXORUBICIN; HEPARIN; LIPOSOME;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CIRCULATION TIME; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG STABILITY; EXPERIMENTAL MODEL; MELANOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; CELL LINE, TUMOR; DOXORUBICIN; HEPARIN; INJECTIONS, INTRAVENOUS; LIPOSOMES; MELANOMA, EXPERIMENTAL; MICE; MYOCARDIUM; NEOPLASM TRANSPLANTATION; PARTICLE SIZE; PROTEIN BINDING;

EID: 33645286473     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.02.007     Document Type: Article

References (31)

1. T.M. Allen, C. Hanser, C. Redemann, and A. Yau-Young Liposomes containing synthetic derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1066 1991 29 36
2. D. Auguste, R. Prud'homme, P. Ahl, P. Meers, and J. Kohn Association of hydrophobically-modified poly(ethylene glycol) with fusogenic liposomes Biochim. Biophys. Acta 1616 2003 184 195
3. G.J.R. Charrois, and T.M. Allen Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer Biochim. Biophys. Acta 1663 2004 167 177
4. P.S. Damus, M. Hicks, and R.B. Rosenberg Heparin: a generalized view of its anticoagulant action Nature 246 1973 355 356
5. D. Drummond, O. Meyer, K. Hong, D. Kirpotin, and D. Papahadjopoulos Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors Pharmacol. Rev. 51 1999 691 743
6. R.E. Eliaz, S. Nir, C. Marty, and F. Szoka Determination and modeling of kinetics of cancer cell killing by doxorubicin and doxorubicin encapsulated in targeted liposomes Cancer Res. 64 2004 711 718
7. A. Gabizon, and D. Papahadjopoulos Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors Proc. Natl. Acad. Sci. U.S.A. 85 1988 6949 6953
8. A. Gabizon, Y. Barenholz, and M. Bialer Prolongation of the circulation time of doxorubicin encapsulated in liposomes containing a polyethylene glycol-derivatized phospholipid: pharmacokinetic studies in rodents and dogs Pharm. Res. 10 1993 703 708
9. G. Haran, R. Cohen, L.K. Bar, and Y. Barenholz Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases Biochim. Biophys. Acta 1151 1993 201 215
10. W. Junping, Y. Maitani, K. Takayama, and T. Nagai In vivo evaluation of doxorubicin carried with long circulating and remote loading proliposome Int. J. Pharm. 203 2000 61 69
11. D.D. Lasic, B. Ceh, M.C.A. Stuart, L. Guo, P.M. Frederik, and Y. Barenholz Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery Biochim. Biophys. Acta 1239 1995 145 156
12. Y.K. Lee, J.H. Nam, H.C. Shin, and Y. Byun Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent Circulation 104 2001 3116 3120
13. W. Lin, M.C. Garnett, M.C. Davies, F. Bignotti, P. Ferruti, S.S. Davis, and L. Illum Preparation of surface-modified albumin nanospheres Biomaterials 18 1997 559 565
14. W.L. Lu, X.R. Qi, Q. Zhang, R.Y. Li, G.L. Wang, R.J. Zhang, and S.L. Wei A pegylated liposomal platform: pharmacokinetics, pharmacodynamics, and toxicity in mice using doxorubicin as a model drug J. Pharmacol. Sci. 95 2004 381 389
15. H. Maeda, L.W. Seymour, and Y. Miyamoto Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo Bioconjug. Chem. 3 1992 351 362
16. M. Mercadal, J.C. Domingo, J. Petriz, J. Garcia, and M.A. Madariaga A novel strategy affords high-yield coupling of antibody to extremities of liposomal surface-grafted PEG chains Biochim. Biophys. Acta 1418 1999 232 238
17. J. Metselaar, P. Bruin, L. de Boer, T. de Vringer, C. Snel, C. Oussoren, M. Wauben, D.A. Crommelin, G. Storm, and W. Hennink A novel family of l-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity Bioconjug. Chem. 14 2003 1156 1164
18. D. Needham, and M.W. Dewhirst The development and testing of a new temperature-sensitive system for the treatment of solid tumors Adv. Drug. Deliv. Rev. 53 2001 285 305
19. D.A. Norris, N. Puri, and P.J. Sinko The effect of physical barriers and properties on the oral adsorption of particulates Adv. Drug. Deliv. Rev. 34 1998 135 154
20. D. Papahadjopoulos, T.M. Allen, A. Gabizon, E. Mayhew, K. Matthay, S.K. Huang, K.D. Lee, M.C. Woodle, D.D. Lasic, C. Redemann, and F.J. Martin Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. U.S.A. 88 1991 11460 11464
21. Y. Sadzuka, A. Nakade, R. Hirama, A. Miyagishima, Y. Nozawa, S. Hirota, and T. Sonobe Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome Int. J. Pharm. 238 2002 171 180
22. A. Sahli, M. Cansell, J. Topon-Bretaudiere, D. Letourneur, J. Jozefonvicz, and A.M. Fischer The stability of heparin-coated liposomes in plasma and their effect on its coagulation Colloid Surf. B 10 1998 205 215
23. H. Takeuchi, H. Kojima, T. Toyoda, H. Yamamoto, T. Hino, and Y. Kawashima Prolonged circulation time of doxorubicin-loaded liposomes coated with a modified polyvinyl alcohol after intravenous injection in rats Eur. J. Pharm. Biopharm. 48 1999 123 129
24. H. Takeuchi, H. Kojima, H. Yamamoto, and Y. Kawashima Polymer coating of liposomes with a modified polyvinyl alcohol and their systemic circulation and RES uptake in rats J. Control. Release 68 2000 195 205
25. H. Takeuchi, H. Kojima, H. Yamanoto, and Y. Kawashima Passive targeting of doxorubicin with polymer coated liposomes in tumor bearing rats Biol. Pharm. Bull. 24 2001 795 799
26. A. Wirsen, M. Ohrlandr, and A.C. Albertsson Bioactive heparin surface from derivatization of polyacrylamide-grafted LLDPE Biomaterials 17 1996 1881 1889
27. N.Z. Wu, D. Da, T.L. Rudoll, D. Needham, A.R. Whorton, and M.W. Dewhirst Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue Cancer Res. 53 1993 3765 3770
28. X.B. Xiong, Y. Huang, W.L. Lu, X. Zhang, H. Zhang, T. Nagai, and Q. Zhang Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo J. Pharm. Sci. 94 2005 1782 1793
29. X.B. Xiong, Y. Huang, W.L. Lu, H. Zhang, X. Zhang, and Q. Zhang Enhanced intracellular uptake of sterically stabilized liposomal doxorubicin in vitro resulting in improved antitumor activity in vivo Pharm. Res. 22 2005 933 939
30. M.B. Yatvin, J.N. Weinstein, W.H. Dennis, and R. Blumenthal Design of liposomes for enhanced local release of drugs by hyperthermia Science 202 1978 1290 1293
31. I. Yoshida, K.I. Tashiro, A. Monji, I. Nagata, Y. Hayashi, Y. Mitsuyama, and N. Tashiro Identification of a heparin binding site and the biological activities of the laminin α1 chain carboxy-terminal globular domain J. Cell. Physiol. 179 1999 18 28